Molina Healthcare Inc
MOH evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for MOH—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper AI · MOH
Molina Healthcare Inc is a pure-play managed care organization focused on government-sponsored healthcare programs, including Medicaid, Medicare, and Marketplace plans.
Key risk: Insufficient capitation rates
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Financial data as of Jun 30, 2026.
Tracking 1 clinical trial for Molina Healthcare Inc.
Molina Healthcare Inc is a pure-play managed care organization focused on government-sponsored healthcare programs, including Medicaid, Medicare, and Marketplace plans.
- Molina Healthcare is a pure-play government-sponsored healthcare business, competing in high-growth, synergistic market segments [sec · filed 2025-03-17].
- As of 2026-06-30, the company reported cash & equivalents of $5,093.0M, total revenue of $10,874.0M, net income of $60.0M, shareholders' equity of $4,603.0M, and total debt of $184.0M [sec].
- The company's strategic priorities include organic growth through new state procurement and contract retention, accretive acquisitions, and reinvesting excess capital or returning it to stockholders [sec · filed 2025-03-17].
- In the six months ended June 30, 2026, financing activity included common stock purchases of $500 million and $650 million in combined borrowings, partially offset by $200 million in repayment [sec_mda · as of 2026-07-23].
- The company believes its cash resources, borrowing capacity, and internally generated funds will be sufficient to support operations, regulatory requirements, debt repayment, and capital expenditures for at least the next period [sec_mda · as of 2026-07-23].
What works
- Molina is a pure-play government-sponsored healthcare business, which provides opportunities to compete in high-growth, synergistic market segments with attractive and sustainable margins [sec · filed 2025-03-17].
- The company has a strong liquidity position with cash & equivalents of $5,093.0M and low total debt of $184.0M as of 2026-06-30 [sec].
- Management has a clear strategy for organic growth through new state procurement, contract retention, and market share expansion, as well as inorganic growth through accretive acquisitions [sec · filed 2025-03-17].
What to weigh
- The company faces risks related to Medicaid, Medicare, or Marketplace capitation rates that may be insufficient to cover medical care costs and utilization rates [sec_mda · as of 2026-04-23].
- Forward-looking statements are subject to numerous known and unknown risks and uncertainties, and actual results may differ significantly from expectations [sec_mda · as of 2026-04-23].
- The company's financial performance is dependent on maintaining strong medical care ratios and general and administrative expense control, which can be impacted by external factors [sec · filed 2025-03-17].
From the filings
Quoted directly from source documents.
Molina is a pure-play government-sponsored healthcare business.
“delivering government-sponsored care.Business StrategyOur long-term growth strategy remains unchanged, as we continue to be a pure-play government-sponsored healthcare business”
SEC filings · March 17, 2025
The company's strategic priorities include organic growth, accretive acquisitions, and capital return.
“Organic growth of our core businesses by growing with new state procurement opportunities, retaining existing contracts, increasing market share in current service areas and pursuing carve-in and/or adjacent opportunities;2.Inorganic growth through accretive acquisitions;3.Reinvesting excess capital in the business or returning it to stockholders (e.g., through share repurchases);”
SEC filings · March 17, 2025
The company believes its cash resources and borrowing capacity are sufficient for near-term obligations.
“We believe that our cash resources, borrowing capacity available under our Credit Agreement as discussed further below in "Future Sources and Uses of Liquidity--Future Sources," and internally generated funds will be sufficient to support our operations, regulatory requirements, debt repayment obligations and capital expenditure”
SEC MD&A · July 23, 2026
Risks include insufficient capitation rates and utilization changes.
“Medicaid, Medicare, or Marketplace capitation rates that are insufficient to fully cover our medical care costs and/or the rates of utilization and the health acuity status of our members”
SEC MD&A · April 23, 2026
Catalyst timeline
- 2025-02-05 · Earnings Report — SEC 8-K filing for earnings report; period N/A.
- 2025-04-23 · Earnings Report — SEC 8-K filing for earnings report; period N/A.
- 2025-07-07 · Earnings Report — SEC 8-K filing for earnings report; period N/A.
- 2025-07-23 · Earnings Report — SEC 8-K filing for earnings report; period N/A.
- 2025-10-22 · Earnings Report — SEC 8-K filing for earnings report; period N/A.
- 2026-02-05 · Earnings Report — SEC 8-K filing for earnings report; period N/A.
- 2026-02-06 · Earnings Report — SEC 8-K filing for earnings report; period N/A.
- 2026-02-26 · Earnings Report — SEC 8-K filing for earnings report; period N/A.
Risks & what to watch (3)›
Key risks
- Insufficient capitation rates — Medicaid, Medicare, or Marketplace capitation rates may be insufficient to cover medical care costs and utilization rates [sec_mda · as of 2026-04-23].
- Forward-looking uncertainties — Actual results may differ significantly due to numerous known and unknown risks and uncertainties [sec_mda · as of 2026-04-23].
- Medical cost ratio pressure — Performance depends on maintaining strong medical care ratios and general and administrative expense control [sec · filed 2025-03-17].
What to watch
- Monitor upcoming earnings reports for financial performance and guidance updates [catalyst].
- Watch for new state procurement opportunities and contract renewals that could drive organic growth [sec · filed 2025-03-17].
- Track changes in Medicaid and Medicare capitation rates and their impact on medical cost ratios [sec_mda · as of 2026-04-23].
- Observe any accretive acquisitions or share repurchase activity as part of capital allocation strategy [sec · filed 2025-03-17].
Sources: Catalysts · SEC filings · SEC MD&A · Generated August 29, 2026 · How we verify sources →
Run Molina Healthcare Inc through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Molina Healthcare Inc facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Evidence & data
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
102.0 months
D/E 2.84 · 0% dilution
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
0 buys · 3 sells (180d)
Runway
Regulatory
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
522
Total value held
$7.03B
| Holder | Shares | Value |
|---|---|---|
| blackrock, inc. | 6,369,026 | $849.0M |
| vanguard capital management llc | 4,620,460 | $615.9M |
| fmr llc | 3,204,924 | $427.2M |
| aqr capital management llc | 2,863,393 | $381.7M |
| vanguard portfolio management llc | 2,790,971 | $372.0M |
| victory capital management inc | 2,070,699 | $276.0M |
| state street corp | 1,730,441 | $230.7M |
| dimensional fund advisors lp | 1,394,882 | $185.9M |
| two sigma investments, lp | 1,366,095 | $182.1M |
| wellington management group llp | 1,131,960 | $150.9M |
Showing top 10 of 522 institutional holders of Molina Healthcare Inc. Open the full 13F history after sign-in.
Short Interest
as of May 10, 2026- % of float
- 6.9%
- Days to cover
- 1.7
- Shares short
- 3,078,804
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
MOH short interestGovernance
Frequently asked questions
What is the AI investment thesis for Molina Healthcare Inc?
Molina Healthcare Inc is a pure-play managed care organization focused on government-sponsored healthcare programs, including Medicaid, Medicare, and Marketplace plans.
Who is the CEO of Molina Healthcare Inc?
Mr. Joseph Michael Zubretsky is the chief executive officer of Molina Healthcare Inc (MOH).
Where is Molina Healthcare Inc headquartered?
Molina Healthcare Inc (MOH) is headquartered in Long Beach, CA, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.